Selasa, 24 Juli 2012

Obesity


Definitions
·         20% or greater above ideal body weight (IBW) (Met. Life Ins. tables); 170% of IBW or BMI > 40 is morbid obesity
·         Most practical index is BMI (body mass index) = weight/height2(kg/m2 )
o   BMI < 20 or > 27 leads to increased health risk

Epidemiology
15-25% of North American adults



Possible Risk Factors
  • Increasing age
  • Genetic - variations in energy expenditure
  • Behaviour/lifestyle - diet and exercise
  • Secondary causes
o   Endocrine: e.g. Cushing’s syndrome, polycystic ovarian disease (PCOD)
o   Drugs: e.g. antidepressants, antiepileptics and antipsychotics
  • Hypothalamic injury: trauma, surgical, lesions in ventromedial or paraventricular median nucleus
Pathophysiology- positive energy balance: energy input > energy output

Complications

Cardiovascular
• Hypertension, CAD, CHF, varicose veins, sudden death from arrhythmia

Respiratory
• dyspnea, sleep apnea, pulmonary embolus, infections

Gastrointestinal
• Gallbladder disease, gastroesophageal reflux disease (GERD), fatty liver

Musculoskeletal
• Osteoarthritis

Endocrine/metabolic
• impaired glucose tolerance (IGT) to type 2 DM, hyperuricemia, hyperlipidemia
• PCOD, hirsutism, irregular menses, infertility

Increased risk of neoplastic diseases
• Endometrial, post-menopausal breast, prostate, colorectal cancers

Treatment

General recommendations
• Treatment should be based on medical risk
• Safest and best therapy is a comprehensive approach including caloric restriction,increased physical activity and behaviour modification

Diet
• Caloric restriction with a balanced diet with reduced fat, sugar and alcohol

Exercise

Behavior modification
• Individual or group therapy
• Self-monitoring, stimulus control, stress management, cognitive change, crisis intervention

Drug therapy
• serotonergic-appetite suppressants fenfluramine-phentermine (Fen-Phen) were found to cause valvular heart disease and primary pulmonary hypertension (withdrawn)
• Pancreatic lipase inhibitor: orlistat (Xenical) found to be mildly to moderately effective 

Surgical therapy
• gastroplasty (“stomach stapling”) is treatment of last resort (controversial)
• Liposuction
• Weight loss is regained by fat accumulation at the same site or elsewhere

2 komentar:

  1. Proto-col Slim-Fizz is a distinct appetite suppressant that contains the groundbreaking fibre Glucomannan, which is a natural soluble fibre extracted from pure Konjac.

    BalasHapus
  2. Research participants needed for a pharmaceutical research study to test an investigational drug for obesity. We are looking for overweight males and females eighteen years or older including those who may have type ii diabetes or have been told that they have fatty liver. Participants must be available for ten outpatient clinic visits over a period of approximately 5 months.
    Enrolled participants will be compensated for time and participation.
    For more information call seaview research at three zero five, six four six, six seven eight five https://studyscavengerapp.com/quotient-sciences-paid-clinical-trial-investigate-efficacy-lik066-obese-patients-volunteers-non-alcoholic-steatohepatitis-fatty-liver-disease-miami-fl/

    #fortlauderdale #miamibeach #obesity

    BalasHapus